Migraine clinical trials in New York
15 studies for Migraine are looking for participants at sites in New York.
Cities in New York
Study of EVO756 in Adults With Migraine
- Clinosis - Dent Neurologic Instite, Amherst
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Oct 2, 2026 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- True North Neurology, Port Jefferson Station
RecruitingPhase 1
Ages 6 to 11 · All sexes · Updated Sep 28, 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Montefiore Medical Center, The Bronx
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 28, 2026 · NCT05156398MMA Embolization for Refractory Chronic Migraine
- University of Buffalo Medical Center, Buffalo
- Mount Sinai, New York
- Stony Brook University Medical Center, Stony Brook
Recruiting
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT06735833A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
- Maimonides Medical Center, Brooklyn
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Sep 24, 2026 · NCT06473597Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Dent Neurosciences Research Center, Amherst
- True North Neurology, Commack
- New York Neurology Associates, New York
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Dent Neurosciences Research Center, Amherst
- True North Neurology, Commack
- Northwell Health IRB, Great Neck
- and 4 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Dent Neurologic Institute - Amherst /ID# 270260, Amherst
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 22, 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Dent Neurological Institute, Amherst
Recruiting
Ages 10 to 17 · All sexes · Updated Sep 21, 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Nuvance Health Institute, Kingston
- Northwell Health, Manhasset
- Mt Sinai Icahn School of Medicine, New York
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Sep 16, 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Dent Neurologic Institute - Amherst /ID# 231182, Amherst
- SUNY Upstate Medical University /ID# 239898, Syracuse
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Dent Neuro Institute, Buffalo, Amherst
- SPRI Clinical Trials, LLC, Brooklyn
- True North Neurology, Commack
- and 4 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 20, 2026 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- True North Neurology, Commack
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Jun 12, 2026 · NCT05164172Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
- Neuroscience Institute at Great Neck, Great Neck
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated May 22, 2026 · NCT07061847RELAXaHEAD for Headache Patients (Phase III)
- NYU Langone Health, New York
Recruiting
Ages 16 to 80 · All sexes · Updated Oct 10, 2025 · NCT06077838From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.